NEW YORK (Reuters) - Shares of Pfizer Inc (PFE.N: Quote, Profile, Research, Stock Buzz) fell 1.3 percent in trading after the bell on Wednesday, after U.S. researchers said data showed serious side effects with the company's smoking drug, Chantix.
Shares fell to $19.74 from its close of $20.01 on the New York Stock Exchange.
(Reporting by Kristina Cooke)
© Thomson Reuters 2008 All rights reserved
Sphere
Betancourt keeps options open
Talk of the Town: It's a boy!
Thousands flee California fire
Courting the Hispanic voter
McCain takes campaign to Colombia
Water-fuel car unveiled in Japan
U.S.-Czech anti-missile deal signed
Police find Uday's luxury cars
It's off with Hitler's waxwork head
Former officials on war powers act
Reuters.com:
Help and Contact Us |
Advertise With Us |
Mobile |
Newsletters |
RSS
|
Interactive TV |
Labs |
Reuters in Second Life |
Archive |
Site Index |
Video Index
Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers
International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
